Related references
Note: Only part of the references are listed.A Microfabricated Sandwiching Assay for Nanoliter and High-Throughput Biomarker Screening
Praveen Bandaru et al.
SMALL (2019)
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Konstantin Kazankov et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
A Human Liver-on-a-Chip Platform for Modeling Nonalcoholic Fatty Liver Disease
Soufian Lasli et al.
ADVANCED BIOSYSTEMS (2019)
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
Banumathi K. Cole et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study
Catherine C. Bell et al.
TOXICOLOGICAL SCIENCES (2018)
Human liver spheroids in chemically defined conditions for studies of gene-drug, drug-drug and disease-drug interactions
Magnus Ingelman-Sundberg et al.
PHARMACOGENOMICS (2018)
Human hepatic 3D spheroids as a model for steatosis and insulin resistance
Mikael Kozyra et al.
SCIENTIFIC REPORTS (2018)
Networked concave microwell arrays for constructing 3D cell spheroids
Geon Hui Lee et al.
BIOFABRICATION (2018)
Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development
Matthew D. Davidson et al.
INTEGRATIVE BIOLOGY (2017)
Three-dimensional perfused human in vitro model of nonalcoholic fatty liver disease
Tomasz Kostrzewski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device
Manuele Gori et al.
PLOS ONE (2016)
Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response
Shyam Sundhar Bale et al.
SCIENTIFIC REPORTS (2016)
A liver-on-a-chip platform with bioprinted hepatic spheroids
Nupura S. Bhise et al.
BIOFABRICATION (2016)
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
Ryan E. Feaver et al.
JCI INSIGHT (2016)
Subtoxic Concentrations of Hepatotoxic Drugs Lead to Kupffer Cell Activation in a Human In Vitro Liver Model: An Approach to Study DILI
Victoria Kegel et al.
MEDIATORS OF INFLAMMATION (2015)
How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Nadia Duarte et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Nonalcoholic fatty liver disease
Elizabeth M. Brunt et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients
Xiaoli Pan et al.
ENDOCRINE (2015)
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
H. H. J. Gerets et al.
CELL BIOLOGY AND TOXICOLOGY (2012)
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Animal models of nonalcoholic fatty liver disease
Lionel Hebbard et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Comparison of primary human hepatocytes and hepatoma cell line HEPG2 with regard to their biotransformation properties
S Wilkening et al.
DRUG METABOLISM AND DISPOSITION (2003)
Share Paper
